Shares of BioTime (BTX -5.5%) slip on profit-taking following two-day rally after the firm...

|By:, SA News Editor

Shares of BioTime (BTX -5.5%) slip on profit-taking following two-day rally after the firm disclosed (8-K) that it entered into two agreements with China-based USCN Life Science to license technology and patents, as well as purchase assets related to stem cell research.